Intco Medical Technology Co., Ltd. (SHE:300677)
China
· Delayed Price · Currency is CNY 36.45
-1.31 (-3.47%)
Sep 29, 2025, 12:44 PM CST
Intco Medical Technology Income Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
|---|---|---|---|---|---|---|---|
Period Ending | Jun '25 Jun 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 | Dec '20 Dec 31, 2020 | 2015 - 2019 |
| Operating Revenue | 9,828 | 9,436 | 6,887 | 6,591 | 16,217 | 13,833 | Upgrade
|
| Other Revenue | 96.4 | 87.33 | 31.36 | 23.21 | 23.28 | 3.42 | Upgrade
|
| Revenue | 9,925 | 9,523 | 6,919 | 6,614 | 16,240 | 13,837 | Upgrade
|
| Revenue Growth (YoY) | 21.99% | 37.65% | 4.61% | -59.27% | 17.37% | 564.29% | Upgrade
|
| Cost of Revenue | 7,546 | 7,347 | 5,976 | 5,776 | 6,267 | 4,292 | Upgrade
|
| Gross Profit | 2,378 | 2,176 | 942.35 | 837.65 | 9,973 | 9,545 | Upgrade
|
| Selling, General & Admin | 848.3 | 806.58 | 738.31 | 614.49 | 929.36 | 567.88 | Upgrade
|
| Research & Development | 412.76 | 398.34 | 283.37 | 252.32 | 365.22 | 293.3 | Upgrade
|
| Other Operating Expenses | 97.58 | 61.81 | 67.29 | 55.39 | 44.07 | 56.04 | Upgrade
|
| Operating Expenses | 1,359 | 1,291 | 1,105 | 907.94 | 1,390 | 927.47 | Upgrade
|
| Operating Income | 1,019 | 885.29 | -162.49 | -70.28 | 8,583 | 8,618 | Upgrade
|
| Interest Expense | -368.63 | -308.04 | -127.74 | -28.46 | -17.61 | -265.41 | Upgrade
|
| Interest & Investment Income | 580.73 | 596.53 | 396.16 | 193.48 | 172.61 | 4.71 | Upgrade
|
| Currency Exchange Gain (Loss) | 110.79 | 225.49 | 133.39 | 548.96 | -103.86 | - | Upgrade
|
| Other Non Operating Income (Expenses) | -24.39 | -23.13 | -16.42 | -8.61 | -10.45 | -31.97 | Upgrade
|
| EBT Excluding Unusual Items | 1,317 | 1,376 | 222.9 | 635.09 | 8,624 | 8,325 | Upgrade
|
| Gain (Loss) on Sale of Investments | 442.86 | 279.77 | 175.57 | 59.67 | 32.66 | 3.18 | Upgrade
|
| Gain (Loss) on Sale of Assets | 0.2 | 0.22 | 0.21 | 2.37 | 0.38 | 0.02 | Upgrade
|
| Asset Writedown | -79.61 | -88.8 | -21.32 | -26.87 | -29.04 | -2.08 | Upgrade
|
| Other Unusual Items | 76.87 | 41.59 | 65.46 | 34.15 | 21.07 | 20.51 | Upgrade
|
| Pretax Income | 1,758 | 1,609 | 442.82 | 704.41 | 8,649 | 8,347 | Upgrade
|
| Income Tax Expense | 131.41 | 117.23 | 54.75 | 65.07 | 1,185 | 1,342 | Upgrade
|
| Earnings From Continuing Operations | 1,626 | 1,492 | 388.06 | 639.34 | 7,463 | 7,005 | Upgrade
|
| Minority Interest in Earnings | -37.48 | -26.21 | -5.07 | -10.27 | -33.4 | 2.54 | Upgrade
|
| Net Income | 1,589 | 1,465 | 383 | 629.07 | 7,430 | 7,007 | Upgrade
|
| Net Income to Common | 1,589 | 1,465 | 383 | 629.07 | 7,430 | 7,007 | Upgrade
|
| Net Income Growth | 134.74% | 282.63% | -39.12% | -91.53% | 6.04% | 3829.56% | Upgrade
|
| Shares Outstanding (Basic) | 639 | 648 | 660 | 662 | 656 | 574 | Upgrade
|
| Shares Outstanding (Diluted) | 639 | 648 | 660 | 662 | 675 | 620 | Upgrade
|
| Shares Change (YoY) | -2.12% | -1.80% | -0.28% | -1.97% | 9.01% | 13.91% | Upgrade
|
| EPS (Basic) | 2.48 | 2.26 | 0.58 | 0.95 | 11.33 | 12.21 | Upgrade
|
| EPS (Diluted) | 2.48 | 2.26 | 0.58 | 0.95 | 11.00 | 11.31 | Upgrade
|
| EPS Growth | 139.83% | 289.65% | -38.95% | -91.36% | -2.73% | 3349.76% | Upgrade
|
| Free Cash Flow | -1,057 | -710.37 | -936.28 | -649.76 | 3,236 | 5,690 | Upgrade
|
| Free Cash Flow Per Share | -1.65 | -1.10 | -1.42 | -0.98 | 4.79 | 9.18 | Upgrade
|
| Dividend Per Share | 0.150 | 0.150 | 0.080 | 0.099 | 0.625 | 1.852 | Upgrade
|
| Dividend Growth | 15.38% | 87.50% | -19.00% | -84.20% | -66.25% | 3236.76% | Upgrade
|
| Gross Margin | 23.96% | 22.85% | 13.62% | 12.67% | 61.41% | 68.98% | Upgrade
|
| Operating Margin | 10.27% | 9.30% | -2.35% | -1.06% | 52.85% | 62.28% | Upgrade
|
| Profit Margin | 16.01% | 15.39% | 5.54% | 9.51% | 45.75% | 50.64% | Upgrade
|
| Free Cash Flow Margin | -10.65% | -7.46% | -13.53% | -9.82% | 19.93% | 41.12% | Upgrade
|
| EBITDA | 1,969 | 1,740 | 557.08 | 556.79 | 8,950 | 8,758 | Upgrade
|
| EBITDA Margin | 19.84% | 18.27% | 8.05% | 8.42% | 55.11% | 63.29% | Upgrade
|
| D&A For EBITDA | 950.52 | 854.69 | 719.57 | 627.08 | 367.24 | 140.02 | Upgrade
|
| EBIT | 1,019 | 885.29 | -162.49 | -70.28 | 8,583 | 8,618 | Upgrade
|
| EBIT Margin | 10.27% | 9.30% | -2.35% | -1.06% | 52.85% | 62.28% | Upgrade
|
| Effective Tax Rate | 7.48% | 7.29% | 12.37% | 9.24% | 13.70% | 16.08% | Upgrade
|
| Revenue as Reported | 9,925 | 9,523 | 6,919 | 6,614 | 16,240 | 13,837 | Upgrade
|
| Advertising Expenses | - | 18.92 | 32.98 | 17.85 | 91.6 | 54.34 | Upgrade
|
Updated Jun 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.